(1)
Safety and Efficacy of Lisdexamfetamine Dimesylate in Attention déficit Hyperactivity Disorder: A Literature Review. RSD 2023, 12 (2), e28412240259. https://doi.org/10.33448/rsd-v12i2.40259.